Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22347)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10652)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1117)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2120)

More Publishers

Results (39668)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mechanisms of resistance to the FLT3-tyrosine kinase inhibitor PKC412 in patients with AML
    Meeting Abstract

    Heidel, F.; Breitenbuecher, F.; Kindler, T.; Solem, F. K.; Carius, B.; Thiede, H. M.; Cohen, P. S.; Roesel, J.; Estey, E. H.; Feldman, E.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Trends in coverage of skin cancer in the print media
    Meeting Abstract

    Hazan, C.; Oliveria, S. A.; Halpern, A. C.
    Journal of Investigative Dermatology (2004)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone (AD-TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Zimman, R.; Hedvat, C. V.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas: Possible effect modification by non-steroidal anti-inflammatory drug use
    Meeting Abstract

    Hartman, T. J.; Yu, B. B.; Albert, P. S.; Brewer, B.; Burt, R.; Caan, B.; Iber, F.; Kikendall, W.; Lance, P.; Marshall, J.; more...
    Cancer Epidemiology Biomarkers and Prevention (2004)

    Fulltext@MSK | Save
  • Primary Mediastinal Large B cell Lymphoma: Elucidating optimal therapy and prognostic factors; an analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980-1999
    Meeting Abstract

    Hamlin, P. A.; Portlock, C. S.; Straus, D. J.; Noy, A.; Horwitz, S. M.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2004)

    Fulltext@MSK | Save
  • The follicular lymphoma international prognostic index (FLIPI) is superior to WHO/REAL histological grade for identifying high-risk patients: A retrospective review of the MSKCC experience in 260 patients with follicular lymphoma
    Meeting Abstract

    Halaas, J. L.; Teruya-Feldstein, J.; Filippa, D. A.; Moskowitz, C.; Naresh, K. N.; Zelenetz, A. D.
    Blood (2004)

    Fulltext@MSK | Save
  • Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Halaas, J. L.; Moskowitz, C. H.; Noy, A.; Portlock, C.; Horwitz, S.; Straus, D.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Results of conventional cytogenetics and interphase FISH (I-FISH) analyses in patients with a clinical and morphologic diagnosis of CML: Analysis of 52 cases
    Meeting Abstract

    Gupta, S.; Berman, E.; Jhanwar, S.
    Blood (2004)

    Fulltext@MSK | Save
  • Tositumomab and iodine I 131 tositumomab (the BEXXAR (R) therapeutic regimen) shows efficacy in elderly patients (pts) with relapsed/refractory low-grade (LG), follicular, and transformed non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Gregory, S. A.; Zelenetz, A.; Knox, S. J.; Vose, J.; Leonard, J. P.; Kaminski, M.
    Blood (2004)

    Fulltext@MSK | Save
  • The iodine I-131 tositumomab therapeutic regimen: Summary of safety in 995 patients with relapsed/refractory low grade (LG) and transformed LG non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Gregory, S. A.; Leonard, J. P.; Knox, S. J.; Zelenetz, A. D.; Armitage, J.; Kaminiski, M.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save